Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEMVAC Vaccine Therapy for HR+ Metastatic Breast Cancer
NCT07112053Phase 2Recruiting
- Sponsor
- University of Washington
- Start
- Nov 2025
- Primary completion
- Jul 2028
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of STEMVAC in breast cancer, sponsored by University of Washington. Started Nov 2025; status: recruiting.
02
Drugs
STEMVAC
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07112053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112053.